Clinical Trials on CMV Infection

Total 61067 results

Fayoum University
Ministry of Health and Population, Egypt

Completed

the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection

SARS-CoV2 Infection

Egypt
University Hospital, Montpellier
Institut Pasteur; UMR ASTRE (CIRAD); UMR PCCEI

Recruiting

Human Epidemiology of Newly Identified Arboviruses (ARBODOCC)

Arbovirus Infections | SARS-CoV Infection

France
University of Minnesota

Completed

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

CMV Viremia | EBV Viremia

United States
CNBG-Virogin Biotech (Shanghai) Ltd.

Recruiting

A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

SARS-CoV-2 Infection

China
CNBG-Virogin Biotech (Shanghai) Ltd.
Shulan (Hangzhou) Hospital

Recruiting

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

SARS-CoV-2 Infection

China
Southeast University, China
Hohhot First Hospital, Hohhot, Inner Mongolia, China

Recruiting

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

SARS-CoV-2 Infection

China
Central Hospital, Nancy, France

Not yet recruiting

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains. (Spread-COVID)

SARS-CoV-2 Infection

France
Columbia University
Gilead Sciences

Recruiting

CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2

COVID-19 | SARS CoV 2 Infection

United States
University of L'Aquila

Recruiting

Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment

COVID-19

Italy
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

COVID-19 | Sars-CoV-2 Infection
Mahidol University
Janssen Pharmaceuticals; International Vaccine Institute; National Vaccine Institute...

Recruiting

Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine

SARS-CoV-2 Infection

Thailand
Halodine LLC

Not yet recruiting

Halodine Nasal Antiseptic in Patients With COVID-19

SARS-CoV-2 Infection
INanoBio Inc.
TMC HealthCare

Recruiting

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Infection

United States
AstraZeneca

Active, not recruiting

A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 (ARTEMIS-C)

COVID-19 | SARS-CoV-2 Infection

United States
WestVac Biopharma Co., Ltd.

Completed

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

Philippines
Sichuan Huiyang Life Science and Technology Corporation

Active, not recruiting

rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19

COVID-19 | SARS-CoV-2 Infection

Philippines
Johns Hopkins University

Completed

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

SARS-CoV-2 Infection

United States
University of Rostock

Completed

Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19

SARS-CoV-2 Infection

Germany
VA Office of Research and Development
Johns Hopkins University

Enrolling by invitation

COVID-19 Observational Research Collaboratory (CORC LTO)

COVID-19 | SARS-CoV-2 Infection

United States
Sinocelltech Ltd.

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

COVID-19 | SARS-CoV-2 Infection
Health Institutes of Turkey

Completed

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

SARS-CoV-2 Infection

China
Novavax

Completed

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

COVID-19 | SARS-CoV-2 Infection

United States, Brazil, South Africa, Germany, Canada, Israel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

SARS-CoV-2 Infection

China
University of Chicago
Rush University Medical Center

Active, not recruiting

Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19

SARS-CoV-2 Infection

United States
Shanghai Zerun Biotechnology Co.,Ltd

Active, not recruiting

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

COVID-19 | SARS-CoV-2 Infection

Mali
Novavax

Completed

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

COVID-19 | SARS-CoV-2 Infection

United Kingdom
BioNTech SE
Pfizer

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults

COVID-19 | SARS-CoV-2 Infection

Japan
BioNTech SE
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

COVID-19 | SARS-CoV-2 Infection

United States
P & B Group
MediAxe CRO

Terminated

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

SARS-CoV-2 Infection

France
Memo Therapeutics AG

Completed

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

SARS-CoV-2 Infection

Australia
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

SARS-CoV-2 Infection

China
University of Pecs
Hungarian Ministry of Innovation and Technology; HECRIN Consortium

Completed

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

SARS-CoV-2 Infection

Hungary
Medicago

Active, not recruiting

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

SARS-CoV-2 Infection

United States, Canada, United Kingdom, Argentina, Brazil, Mexico
Eshmoun Clinical Research Center

Completed

I VACCIN Hospitalization of COVID-19 Patients

COVID-19 | SARS CoV 2 Infection

Tunisia
Celltrion

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

SARS-CoV-2 Infection

Korea, Republic of
Dentaid SL
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. (CPC COVID)

SARS-CoV-2 Infection

Spain
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

COVID-19

Argentina
Roberto Poscia MD, PhD

Unknown

Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID)

Coronavirus Infection | Pneumonia, Viral | SARS-CoV 2 | COVID

Italy
Lophius Biosciences GmbH

Completed

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients (CMValue)

Kidney Transplantation | Cytomegalovirus | CMV Specific Immune Response

Germany
Imam Abdulrahman Bin Faisal University
King Abdulaziz University; Ministry of Health, Saudi Arabia

Completed

Saudi Outcomes of ECMO-treated MERS-CoV Patients

Refractory Hypoxemia | MERS-CoV Infection

Saudi Arabia
Serge Thal

Completed

Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity

SARS-CoV2 Infection | Tolerance | Immunisation Reaction | Antibody Hypersensitivity

Germany
Fayoum University

Completed

Diode Laser 940 nm in Management of Loss of Taste Sensation

SARS-CoV Infection

Egypt
Bangkok Metropolitan Administration Medical College...

Completed

SARS-COV-2 Detection From Used Surgical Mask

SARS-CoV-2 Virus

Thailand

3

Subscribe